{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:02:01Z","timestamp":1740106921866,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100013226","name":"Les Laboratories Pierre Fabre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00277-019-03704-z","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T12:46:45Z","timestamp":1558442805000},"page":"1973-1980","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)"],"prefix":"10.1007","volume":"98","author":[{"given":"J\u00e9r\u00f4me","family":"Cornillon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Daguenet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques-Olivier","family":"Bay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien","family":"Chauchet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Salles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Contentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Nicolas-Virelizier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Vallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda","family":"Alexis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Lorraine","family":"Chr\u00e9tien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Cluzeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Himberlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Dorvaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandy","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Lejeune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9gis Peffault","family":"de Latour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Gyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,20]]},"reference":[{"key":"3704_CR1","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A, Somers R, van der Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn JY, Harousseau JL, Coiffier B, Biron P, Mandelli F, Chauvin F (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin\u2019s lymphoma. N Engl J Med 333:1540\u20131545. \n                    https:\/\/doi.org\/10.1056\/NEJM199512073332305","journal-title":"N Engl J Med"},{"key":"3704_CR2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1200\/JCO.1995.13.3.588","volume":"13","author":"W Mills","year":"1995","unstructured":"Mills W, Chopra R, McMillan A, Pearce R, Linch DC, Goldstone AH (1995) BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin\u2019s lymphoma. J Clin Oncol Off J Am Soc Clin Oncol 13:588\u2013595. \n                    https:\/\/doi.org\/10.1200\/JCO.1995.13.3.588","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"3704_CR3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1200\/JCO.1999.17.1.222","volume":"17","author":"M Andre","year":"1999","unstructured":"Andre M, Henry-Amar M, Pico JL et al (1999) Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin\u2019s disease induction failure: a case-control study. J Clin Oncol 17(1):222\u2013229. \n                    https:\/\/doi.org\/10.1200\/JCO.1999.17.1.222","journal-title":"J Clin Oncol"},{"key":"3704_CR4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/sj.bmt.1705744","volume":"40","author":"HF Fernandez","year":"2007","unstructured":"Fernandez HF, Escal\u00f3n MP, Pereira D, Lazarus HM (2007) Autotransplant conditioning regimens for aggressive lymphoma: are we on the right road? Bone Marrow Transplant 40:505\u2013513. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1705744","journal-title":"Bone Marrow Transplant"},{"key":"3704_CR5","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.bbmt.2015.02.005","volume":"21","author":"Y-B Chen","year":"2015","unstructured":"Chen Y-B, Lane AA, Logan BR, Zhu X, Akpek G, Aljurf MD, Artz AS, Bredeson CN, Cooke KR, Ho VT, Lazarus HM, Olsson RF, Saber W, McCarthy PL, Pasquini MC (2015) Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant 21:1046\u20131053. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2015.02.005","journal-title":"Biol Blood Marrow Transplant"},{"key":"3704_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/sj.bmt.1702795","volume":"27","author":"A Salar","year":"2001","unstructured":"Salar A, Sierra J, Gandarillas M, Caballero MD, Mar\u00edn J, Lahuerta JJ, Garc\u00eda-Conde J, Arranz R, Le\u00f3n A, Zuazu J, Garc\u00eda-Lara\u00f1a J, L\u00f3pez-Guillermo A, Sanz MA, Gra\u00f1ena A, Garc\u00eda JC, Conde E, GEL\/TAMO Spanish Cooperative Group (2001) Autologous stem cell transplantation for clinically aggressive non-Hodgkin\u2019s lymphoma: the role of preparative regimens. Bone Marrow Transplant 27:405\u2013412. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1702795","journal-title":"Bone Marrow Transplant"},{"key":"3704_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00277-007-0360-0","volume":"87","author":"J-C Jo","year":"2007","unstructured":"Jo J-C, Kang BW, Jang G, Sym SJ, Lee SS, Koo JE, Kim JW, Kim S, Huh J, Suh C (2007) BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin\u2019s lymphoma patients: comparative analysis of efficacy and toxicity. Ann Hematol 87:43\u201348. \n                    https:\/\/doi.org\/10.1007\/s00277-007-0360-0","journal-title":"Ann Hematol"},{"key":"3704_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bmt.2016.340","volume-title":"Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review","author":"G Damaj","year":"2017","unstructured":"Damaj G, cornillon J, Bouabdallah K et al (2017) Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review. Nature Publishing Group, London, pp 1\u20139. \n                    https:\/\/doi.org\/10.1038\/bmt.2016.340"},{"key":"3704_CR9","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1080\/10428194.2016.1185785","volume":"57","author":"A Isidori","year":"2016","unstructured":"Isidori A, Christofides A, Visani G (2016) Novel regimens prior to autologous stem cell transplantation for the management of adults with relapsed\/refractory non-Hodgkin lymphoma and Hodgkin lymphoma: alternatives to BEAM conditioning. Leuk Lymphoma 57:2499\u20132509. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(15)60165-9","journal-title":"Leuk Lymphoma"},{"key":"3704_CR10","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1023\/A:1008343823292","volume":"10","author":"P Brice","year":"1999","unstructured":"Brice P, Divine M, Simon D, Coiffier B, Leblond V, Simon M, Voilat L, Devidas A, Morschhauser F, Rohrlich P, Andr\u00e9 M, Lepage E, Ferme C, SFGM\/GELA Study Group (1999) Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin\u2019s disease (HD). SFGM\/GELA study group. Ann Oncol 10:1485\u20131488","journal-title":"Ann Oncol"},{"key":"3704_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1046\/j.1365-2141.2002.03636.x","volume":"118","author":"AR Jonkhoff","year":"2002","unstructured":"Jonkhoff AR, De Kreuk AM, Franschman G et al (2002) Granulocyte colony-stimulating factor mobilized whole blood containing over 0.3 x 106\/kg CD34+ cells is a sufficient graft in autologous transplantation for relapsed non-Hodgkin\u2019s lymphoma. Br J Haematol 118:90\u2013100","journal-title":"Br J Haematol"},{"key":"3704_CR12","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1080\/10428190500527769","volume":"47","author":"N Puig","year":"2009","unstructured":"Puig N, de la Rubia J, Remigia MJ et al (2009) Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation. Leuk Lymphoma 47:1488\u20131494. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1704110","journal-title":"Leuk Lymphoma"},{"key":"3704_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/2193-1801-2-489","volume":"2","author":"A Sharma","year":"2013","unstructured":"Sharma A, Kayal S, Iqbal S, Malik PS, Raina V (2013) Comparison of BEAM vs. LEAM regimen in autologous transplant for lymphoma at AIIMS. Springerplus 2:489. \n                    https:\/\/doi.org\/10.1186\/2193-1801-2-489","journal-title":"Springerplus"},{"key":"3704_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.leukres.2010.07.016","volume":"35","author":"JE Kim","year":"2011","unstructured":"Kim JE, Lee DH, Yoo C, Kim S, Kim SW, Lee JS, Park CJ, Huh J, Suh C (2011) BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: a single center comparative analysis of efficacy and toxicity. Leuk Res 35:183\u2013187. \n                    https:\/\/doi.org\/10.1016\/j.leukres.2010.07.016","journal-title":"Leuk Res"},{"key":"3704_CR15","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1200\/JCO.2012.45.9453","volume":"31","author":"JM Vose","year":"2013","unstructured":"Vose JM, Carter S, Burns LJ, Ayala E, Press OW, Moskowitz CH, Stadtmauer EA, Mineshi S, Ambinder R, Fenske T, Horowitz M, Fisher R, Tomblyn M (2013) Phase III randomized study of rituximab\/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab\/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trial. J Clin Oncol 31:1662\u20131668. \n                    https:\/\/doi.org\/10.1200\/JCO.2012.45.9453","journal-title":"J Clin Oncol"},{"key":"3704_CR16","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.bbmt.2012.10.029","volume":"19","author":"Y Nieto","year":"2013","unstructured":"Nieto Y, Popat U, Anderlini P, Valdez B, Andersson B, Liu P, Hosing C, Shpall EJ, Alousi A, Kebriaei P, Qazilbash M, Parmar S, Bashir Q, Shah N, Khouri I, Rondon G, Champlin R, Jones RB (2013) Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin\u2019s lymphoma: effect of the specific high-dose chemotherapy regimen on outcome. Biol Blood Marrow Transplant 19:410\u2013417. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2012.10.029","journal-title":"Biol Blood Marrow Transplant"},{"key":"3704_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/sj.bmt.1700913","volume":"20","author":"MD Caballero","year":"1997","unstructured":"Caballero MD, Rubio V, Rifon J, Heras I, Garc\u00eda-Sanz R, V\u00e1zquez L, Vidriales B, Ca\u00f1izo MC, Corral M, Gonzalez M, Le\u00f3n A, Jean-Paul E, Rocha E, Moraleda JM, Miguel JFS (1997) BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors. Bone Marrow Transplant 20:451\u2013458. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1700913","journal-title":"Bone Marrow Transplant"},{"key":"3704_CR18","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1182\/blood-2005-01-0035","volume":"105","author":"S Bhatia","year":"2005","unstructured":"Bhatia S, Robison LL, Francisco L, Carter A, Liu Y, Grant M, Baker KS, Fung H, Gurney JG, McGlave P, Nademanee A, Ramsay NK, Stein A, Weisdorf DJ, Forman SJ (2005) Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood 105:4215\u20134222. \n                    https:\/\/doi.org\/10.1182\/blood-2005-01-0035","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03704-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-019-03704-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03704-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T23:13:20Z","timestamp":1589843600000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-019-03704-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,20]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["3704"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03704-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2019,5,20]]},"assertion":[{"value":"20 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"EG received research support from Pierre Fabre. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the SFGM-TC scientific council and performed according to the SFGM-TC guidelines and in accordance with the principles of the declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}